20,000 Shares in MeiraGTx Holdings plc (NASDAQ:MGTX) Bought by PUREfi Wealth LLC

PUREfi Wealth LLC bought a new position in shares of MeiraGTx Holdings plc (NASDAQ:MGTX) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 20,000 shares of the company’s stock, valued at approximately $122,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets boosted its stake in MeiraGTx by 142.5% during the 3rd quarter. BNP Paribas Financial Markets now owns 9,319 shares of the company’s stock worth $39,000 after purchasing an additional 5,476 shares during the last quarter. China Universal Asset Management Co. Ltd. boosted its stake in MeiraGTx by 97.0% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company’s stock worth $62,000 after purchasing an additional 7,330 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in MeiraGTx by 19.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company’s stock worth $75,000 after purchasing an additional 2,839 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of MeiraGTx during the 3rd quarter valued at about $82,000. Finally, Janney Montgomery Scott LLC acquired a new position in shares of MeiraGTx during the 4th quarter valued at about $459,000. Institutional investors and hedge funds own 67.48% of the company’s stock.

Wall Street Analyst Weigh In

MGTX has been the topic of several recent research reports. Chardan Capital reissued a “buy” rating and set a $36.00 price target on shares of MeiraGTx in a research report on Monday, November 18th. Royal Bank of Canada boosted their price target on shares of MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research report on Thursday, November 14th.

Insiders Place Their Bets

In related news, CEO Alexandria Forbes sold 35,839 shares of the company’s stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $6.47, for a total transaction of $231,878.33. Following the sale, the chief executive officer now directly owns 1,395,102 shares in the company, valued at approximately $9,026,309.94. This represents a 2.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Richard Giroux sold 24,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $6.29, for a total transaction of $150,960.00. Following the sale, the chief financial officer now owns 849,947 shares in the company, valued at $5,346,166.63. The trade was a 2.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 8.40% of the company’s stock.

MeiraGTx Stock Up 1.5 %

Shares of NASDAQ:MGTX opened at $6.70 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34. The firm has a market capitalization of $523.63 million, a PE ratio of -5.54, a price-to-earnings-growth ratio of 0.38 and a beta of 1.25. The firm’s 50-day moving average is $6.25 and its two-hundred day moving average is $5.47. MeiraGTx Holdings plc has a 1 year low of $3.85 and a 1 year high of $7.37.

MeiraGTx Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.